Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
grade C 131.39 -0.27% -0.36
JNJ closed down 0.27 percent on Friday, September 22, 2017, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical JNJ trend table...

Date Alert Name Type % Chg
Sep 22 50 DMA Resistance Bearish 0.00%
Sep 22 NR7 Range Contraction 0.00%
Sep 22 MACD Bearish Signal Line Cross Bearish 0.00%
Sep 21 Fell Below 50 DMA Bearish -0.27%
Sep 20 Stochastic Sell Signal Bearish -1.37%

Older signals for JNJ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Is JNJ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 136.2135
52 Week Low 107.2027
Average Volume 5,304,150
200-Day Moving Average 124.1146
50-Day Moving Average 132.3267
20-Day Moving Average 132.3875
10-Day Moving Average 133.391
Average True Range 1.6959
ADX 16.28
+DI 18.08
-DI: 18.84
Chandelier Exit (Long, 3 ATRs) 130.7023
Chandelier Exit (Short, 3 ATRs) 134.8077
Upper Bollinger Band 135.3275
Lower Bollinger Band 129.4475
Percent B (%b) 0.33
Bandwidth 0.044415
MACD Line 0.2712
MACD Signal Line 0.3365
MACD Histogram -0.0653